Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study

ABSTRACT Introduction: the use of palivizumab as prophylaxis of the respiratory syncytial virus is not a consensus. In Brazil, it is a public health program, but other countries do not consider it cost-effective. Objective: to identify the rate of hospitalization in Intensive Care Unit for respira...

Full description

Bibliographic Details
Main Authors: Ivana Regina Gonçalves, Marli Teresinha Cassamassimo Duarte, Helio Rubens de Carvalho Nunes, Rubia de Aguiar Alencar, Cristina Maria Garcia de Lima Parada
Format: Article
Language:English
Published: Universidade de São Paulo 2017-09-01
Series:Revista Latino-Americana de Enfermagem
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692017000100371&lng=en&tlng=en